Both feature a similar base of regulations, with a few tweaks, and both can compete in either WEC or IMSA. Le Mans Daytona h (LMDh): LMDh regulations mandate that a chassis must be built by one of ...
DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this site. This service is intended for adult audiences. No guarantees are made ...
Copyright 2025 The Associated Press. All Rights Reserved. Tech executive and part-time racer Ben Sloss shows off the helmet designed by his wife Christine, Thursday ...
While the origin point of muscle cars is hotly debated, there is one fact from the mid-1960s that is settled: The Pontiac GTO will forever be an icon. The first-generation Goat put all the power of ...
When most people think “Pontiac GTO,” the first thing that comes to mind is the ’60s car, not today’s Nice Price or No Dice Aussie import reconstitution. Let’s see if this well-equipped ...
Meanwhile, Magnussen was announced as a works driver for BMW M Motorsport, and will compete in the IMSA SportsCar Championship. The Dane returned to the track in a test ahead of the Daytona 24 Hours, ...
The first 60 minutes and last two hours will air on NBC. USA, IMSA.TV and YouTube will share the middle portions. After that, IMSA, NASCAR’s sports-car cousin, will hibernate for six weeks.
'It's a Beautiful Time' to Be a Driver in the IMSA WeatherTech SportsCar Series, Rolex 24 at Daytona
Increased opportunities are part of the rising tide created by the convergence of hybrid prototype rules between IMSA and the World Endurance Championship. The demand for drivers is fueled in part ...
The IMSA schedule offers an array of long days. Ten-hour race? Challenging. Twelve-hour race? Demanding. Twenty-four-hour race? A whole different ballgame. “Full transparency, this is the ...
The Roar Before the Rolex 24 weekend at Daytona not only featured the opening rounds of the IMSA VP Racing Sportscar Challenge, but also the RAFA Racing Team’s IMSA Michelin Pilot Challenge ...
IMSA-101 is under clinical development by ImmuneSensor Therapeutics and currently in Phase II for Hematological Tumor. According to GlobalData, Phase II drugs for Hematological Tumor does not have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback